Lantern Pharma (LTRN) Tops Q4 EPS by 1c

Lantern Pharma (NASDAQ: LTRN) reported Q4 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c
• Owlet (OWLT) Tops Q2 EPS by 9c